Eli Lilly (LLY) Change in Cash (2009 - 2026)

Eli Lilly has reported Change in Cash for 18 years, with the latest figure at -$2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 1034.86% year-over-year to -$2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (up 246.14% YoY), and the FY2025 full-year result was $4.0 billion, up 790.87% from the prior year.
• Change in Cash for Q1 2026 stood at -$2.0 billion, up from -$2.5 billion in the prior quarter.
• The five-year high for Change in Cash was $6.4 billion in Q3 2025, with the low at -$2.5 billion in Q4 2025.
• Historically, Change in Cash has averaged $86.1 million across 5 years, with a median of -$101.4 million in 2024.
• Annual changes were most pronounced in 2023 — Change in Cash tumbled 5603.64% — and 2025, when it surged 4312.65%.
• Eli Lilly's Change in Cash stood at -$550.4 million in 2022, then soared by 179.61% to $438.2 million in 2023, then slumped by 123.14% to -$101.4 million in 2024, then sank by 2388.66% to -$2.5 billion in 2025, then gained by 21.3% to -$2.0 billion in 2026.
• The last three Change in Cash figures came in at -$2.0 billion (Q1 2026), -$2.5 billion (Q4 2025), and $6.4 billion (Q3 2025), per Business Quant data.